Sfoglia per Autore
The newt ribozyme is part of a riboprotein complex.
1997 Luzi E; Eckstein F; Barsacchi G.
Intermolecular cleavage by the newt ribozyme.
1997 Marusic L; Luzi E; Barsacchi G; Eckstein F.
Designing ribozymes for the inhibition of gene expression.
1998 Bramlage B; Luzi E; Eckstein F.
HIV-1 LTR as a target for synthetic ribozyme-mediated inhibition of gene expression: site selection and inhibition in cell culture.
2000 Bramlage B; Luzi E; Eckstein F.
PHOSPHODIESTER OLIGONUCLEOTIDES INHIBIT MITOSIS AND TRIGGER APOPTOSIS BY A NON-ANTISENSE, P53-MEDIATED MECHANISM.
2002 L. PAPUCCI;N. SCHIAVONE; M. DONNINI; A. LAPUCCI; E. LUZI; A. TEMPESTINI; E. WITORT; S. CAPACCIOLI
Downregulation of bcl-2 expression in lymphoma cells by bcl-2 ARE-targeted modified, synthetic ribozyme.
2003 LUZI E.; PAPUCCI L.; N. SCHIAVONE; DONNINI M.; LAPUCCI A.; TEMPESTINI A.; WITORT E.; NICOLIN A.; CAPACCIOLI S.
Aptamer-based biosensors for the detection of HIV-1 TAT protein
2005 S. Tombelli; M. Minunni; E. Luzi; M. Mascini;
Multiple Endocrine Neoplasia Type 2.
2006 MARINI F; FALCHETTI A; DEL MONTE F; CARBONELL SALA S; TOGNARINI I.; LUZI E; M.L. BRANDI
Multiple endocrine neoplasia type 1.
2006 MARINI F; FALCHETTI A; MONTE FD; SALA SC; GOZZINI A; LUZI E; M.L. BRANDI
Haplotype analysis of two pairs of unrelated Italian families affected by Paget's disease of bone, exhibiting different geographical origins and two different mutations of p62/sequestosomel gene, supports the evidence for common founders.
2006 A. Falchetti;M. D. Stefano;F. Marini;L. Masi;F. Giusti;C. Cepollaro;E. Luzi;V. Martineti;C. Mavilia;D. Strigoli;S. Bergui;G. Isaia;M. L. Brandi
Multiple endocrine neoplasms
2008 Falchetti A; Marini F; Luzi E; Tonelli F; Brandi ML.
Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis
2008 F. Marini; A. Falchetti; S. Silvestri; Y. Bagger; E. Luzi; A. Tanini; C. Christiansen; M. L. Brandi
Osteogenic differentiation of human adipose tissue-derived stem cells is modulated by the miR-26a targeting of the SMAD1 transcription factor.
2008 E. Luzi; F. Marini; S. Carbonell Sala; I. Tognarini; G. Galli; M. L. Brandi
Germline mutations in MEN1 and BRCA1 genes in a woman with familial multiple endocrine neoplasia type 1 and inherited breast-ovarian cancer syndromes: a case report.
2009 L.Papi; D.Palli; L.Masi; A.L.Putignano; C.Congregati; I.Zanna; F. Marini; F.Giusti; E.Luzi; F.Tonelli; M.Genuardi; M.L.Brandi; A.Falchetti
Multiple endocrine neoplasia type 1 (MEN1): not only inherited endocrine tumors.
2009 A. Falchetti;F. Marini;E. Luzi;F. Giusti;L. Cavalli;T. Cavalli;M. L. Brandi
Mammalian Pumilio 2 regulates dendrite morphogenesis and synaptic function.
2010 Vessey JP; Schoderboeck L; Gingl E; Luzi E; Riefler J; Di Leva F; Karra D; Thomas S; Kiebler MA; Macchi P.
Ribozyme-mediated compensatory induction of menin-oncosuppressor function in primary fibroblasts from MEN1 patients.
2010 E. Luzi; F. Marini; I. Tognarini; S. Carbonell sala; G. Galli; A. Falchetti; M.L. Brandi
MicroRNA Role in Thyroid Cancer Development.
2011 F. Marini; E. Luzi; M. L. Brandi
Are microRNAs involved in the endocrine-specific pattern of tumorigenesis in multiple endocrine neoplasia type 1?
2011 E. Luzi; M. L. Brandi
Ione bivalente stronzio: effetti sulla proliferazione e la differenziazione osteogenica in vitro della linea clonale PA20-h5, preparata da cellule staminali mesenchimali umane da tessuto adiposo.
2012 S. Ciuffi; S. Fabbri; V. Nardone; F. Marini; C. Romagnoli; R. Zonefrati; C. Mavilia; G. Galli; E. Luzi; A. Tanini; M.L. Brandi
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile